Association of IL23R p.381Gln and ATG16L1 p.197Ala With Crohn Disease in the Czech Population

Autoři

DUSATKOVA Petra HRADSKY Ondrej LENICEK Martin BRONSKY Jiri NEVORAL Jiri KOTALOVA Radana BAJEROVÁ Kateřina VITEK Libor LUKAS Milan CINEK Ondrej

Rok publikování 2009
Druh Článek v odborném periodiku
Časopis / Zdroj Journal of Pediatric Gastroenterology and Nutrition
Fakulta / Pracoviště MU

Lékařská fakulta

Citace
www https://journals.lww.com/jpgn/Fulltext/2009/10000/Association_of_IL23R_p_381Gln_and_ATG16L1_p_197Ala.6.aspx
Klíčová slova Age at onset; ATG16L1; Crohn disease; Genetic association; IL23R
Popis Objectives: An association of variants in the genes encoding the interleukin 23 receptor (IL23R, p.Arg381Gln, rs11209026), and the autophagy-related gene 16-like 1 (ATG16L1, p.Ala197Thr, rs2241880) with Crohn disease (CD) was identified by whole genome association studies, and subsequently confirmed by other works. The aim of this study was to assess this association in the Czech population. Subjects and Methods: In a case-control study 333 patients with CD (137 paediatric and 196 adult-onset) and 499 unrelated healthy controls were genotyped using TaqMan SNP assays. Results: The IL23R p.381Gln allele was protective against CD in the Czech population (allelic frequency 3.2% in patients vs 5.5% in control subjects; OR 0.56, 95% CI 0.33-0.93, P=0.02). ATG16L1 p.197Ala allele conferred increased risk of CD (allelic frequency 60% in patients vs 51% in controls; OR 1.25, 95% CI 1.02-1.52, P=0.03). There was no appreciable difference in the effect of the associated alleles across the strata of CARD15-conferred risk. The IL23R and ATG16L1 variants did not influence the age at diagnosis, and in the genotype-phenotype analysis, the only detected association was a weak one between IL23R p.381Gln and involvement of the upper gastrointestinal tract (uncorrected P=0.031). Conclusions: We confirmed the role of IL23R and ATG16L1 in the CD susceptibility in the Czech population, and found a weak protective effect of IL23R p.381Gln against upper gastrointestinal tract involvement. JPGN 49:405-410, 2009.

Používáte starou verzi internetového prohlížeče. Doporučujeme aktualizovat Váš prohlížeč na nejnovější verzi.

Další info